CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Providing of Topical Items
PlusCBD™ Oil Roll-On release at 945 Kroger shops in 17 U.S. States
LAS VEGAS, NEVADA, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD items, is very happy to announce further expansion of its industry-dominating PlusCBD™ Oil brand name utilizing the Kroger Co. (NYSE:KR).
The Company’s expanded retail circulation includes the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across a lot of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and cbd or thc for pain Smiths areas in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and additional Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant components, warming camphor and menthol that is cooling. Created using its Gold Formula focused full spectrum hemp extract, the Roll-Ons offer high strength help in a application that is easy-to-use. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms may also be available at the participating Kroger areas. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As talked about regarding the Company’s quarter that is first earnings turn to May 8, 2019, CV Sciences’ recent circulation gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy shops. With the help of 945 Kroger places and distribution that is new other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are for sale in 4,591 stores, up from 3,308 stores at the time of March 31, 2019, a rise of 38.7% on the prior 2 months.
“We are happy to partner with Kroger and introduce our Roll-On that is new topical we carry on our quick expansion in to the FDM channel,” said Joseph Dowling, Chief Executive Officer. “Kroger, CVS Pharmacy, and other leading national retailers are keenly conscious of the increased customer need for hemp-based CBD items and they’re partnering with CV Sciences because of our commitment that is unwavering to and quality. Our company is at the start of that which we think will likely to be acceptance that is broad of products across national FDM reports and then we look forward to our continued growth once we increase shop count and SKUs with your retail lovers.”
PlusCBD™ Oil Extra Strength Balm ranks number 1 in sales in both the Total U.S. Natural Channel and complete U.S. MULO (Multi Outlet) throughout the last 52 months* among CBD products within Topical Analgesics, based on SPINS and IRI data, correspondingly. Brightfield Group, a number one predictive analytics and researching the market company for the CBD market, expects $1.3 billion in product product sales of CBD topicals in 2019, having an ingredient growth that is annual of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two distinct company portions: a consumer item unit centered on production, advertising and attempting to sell plant-based CBD products to a variety of market sectors; and a drug development unit focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil may be the brand that is top-selling of CBD available on the market, relating to SPINS, the best provider of syndicated information and insights when it comes to normal, organic and specialty items industry. CV Sciences, Inc. has offices that are primary facilities in north park, Ca and vegas, Nevada. More information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.
This news release may include particular statements that are forward-looking information, as defined in the concept of Section 27A for the Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is susceptible to the Safe Harbor produced by those parts. This product contains statements about anticipated future events and/or economic results which are forward-looking in nature and susceptible to dangers and uncertainties. Such statements that are forward-looking meaning incorporate dangers, uncertainties.